Literature DB >> 34128561

COVID-19 vaccine anaphylaxis: IgE, complement or what else? A reply to: "COVID-19 vaccine anaphylaxis: PEG or not?"

Beatriz Cabanillas1, Cezmi A Akdis2,3, Natalija Novak4.   

Abstract

Entities:  

Year:  2021        PMID： 34128561     DOI： 10.1111/all.14725

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  8 in total

1.  COVID-19 Vaccination Is Safe among Mast Cell Disorder Patients, under Adequate Premedication.

Authors:  Tiago Azenha Rama; Joana Miranda; Diana Silva; Luís Amaral; Eunice Castro; Alice Coimbra; André Moreira; José Luís Plácido
Journal:  Vaccines (Basel)       Date:  2022-05-04

2.  Recent advances and developments in COVID-19 in the context of allergic diseases.

Authors:  Mei Ding; Xiang Dong; Yuan-Li Sun; Milena Sokolowska; Mübeccel Akdis; Willem van de Veen; Ahmet Kursat Azkur; Dilek Azkur; Cezmi A Akdis; Ya-Dong Gao
Journal:  Clin Transl Allergy       Date:  2021-09       Impact factor: 5.657

Review 3.  Anaphylaxis to additives in vaccines.

Authors:  Vera Mahler; Ann-Christine Junker
Journal:  Allergo J Int       Date:  2022-06-14

4.  Allergic reactions to COVID-19 vaccinations-unveiling the secret(s).

Authors:  Oliver Pfaar; Vera Mahler
Journal:  Allergy       Date:  2021-06       Impact factor: 14.710

Review 5.  COVID-19 phase 4 vaccine candidates, effectiveness on SARS-CoV-2 variants, neutralizing antibody, rare side effects, traditional and nano-based vaccine platforms: a review.

Authors:  Faizan Zarreen Simnani; Dibyangshee Singh; Ramneet Kaur
Journal:  3 Biotech       Date:  2021-12-12       Impact factor: 2.406

6.  The value of the basophil activation test in the evaluation of patients reporting allergic reactions to the BNT162b2 mRNA COVID-19 vaccine.

Authors:  Marina Labella; Jose Antonio Céspedes; Inmaculada Doña; Mohamed H Shamji; Ioana Agache; Cristobalina Mayorga; Maria José Torres
Journal:  Allergy       Date:  2021-10-31       Impact factor: 14.710

Review 7. 

Authors:  Vera Mahler; Ann-Christine Junker
Journal:  Allergo J       Date:  2022-07-25

8.  Evaluation of the Autoimmunity and Preexisting Risky Conditions for Hypersensitivity Reactions to COVID-19 Vaccines.

Authors:  Can Tuzer; Kadriye Terzioglu
Journal:  Int Arch Allergy Immunol       Date:  2022-02-03       Impact factor: 3.767
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.